fda ends semaglutide shortage The Wegovy Continues, Leaving Patients On the Weight Loss Drug in Limbo Novo Nordisk, FDA Score Win

Fewer than 1% of tirzepatide patients in SURPASS trials discontinued due to nausea at any dose level

After an initial assessment, well determine whether youre a viable candidate and create a personalized treatment plan that includes counseling and exercise regimes

The absence from the drug label does not mean the connection is not real

Get a fresh supply and titrate properly

The key distinction is that while Ozempic is primarily approved for diabetes treatment, semaglutide in other forms is designed specifically for weight loss

However, everyone responds differently, and what matters most is finding the treatment that works for your body and fits your lifestyle